SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 18 of 100
Health
Ozempic manufacturer Novo Nordisk spent $11 million last year ‘wining and dining’ doctors. Experts slam the move as a breach of doctor-patient trust
By
Erin Prater
July 21, 2023
Newsletters
Digitalization could be the answer to better health care for patients. But first, they need to trust it
By
Eamon Barrett
July 21, 2023
Health
Biden administration pushes Walgreens, CVS and Walmart to tout drug cost benefits of Inflation Reduction Act as drugmakers sue government
By
Riley Griffin
and
Bloomberg
July 19, 2023
Finance
The A.I. mania is so red hot that a small $50 million investment from Nvidia sent an obscure biotech firm’s shares up a record 78%
By
Angel Adegbesan
and
Bloomberg
July 12, 2023
Health
Ozempic isn’t alone. A whole class of ‘revolutionary’ weight-loss drugs is on the market—but only for the wealthy
By
Rachel Shin
July 9, 2023
Success
Eli Lilly’s CEO pinpoints the 3-prong problem big execs face with remote work
By
Jane Thier
June 24, 2023
Features
The maker of Ozempic and Wegovy is researching groundbreaking new drugs to stop people from becoming obese in the first place
By
Vivienne Walt
June 21, 2023
Health
The ADHD drug shortage is spreading as supplies of a popular alternative to Adderall run worryingly low
By
Ike Swetlitz
and
Bloomberg
June 20, 2023
Success
Gen Z needs brand-new skills to climb to the C-suite: ‘What got me here will not get them there,’ says health care CEO
By
Jane Thier
June 2, 2023
Leadership
GSK’s CEO says you need thick skin if you’re going to step into the C-suite
By
Fortune Editors
May 31, 2023
Commentary
Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars
By
Giacomo Chiesi
May 25, 2023
Health
A Colorado panel of medical and pharmacy experts will decide whose medicine to make affordable this summer
By
Markian Hawryluk
and
KFF Health News
May 22, 2023
Commentary
Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’
By
Paul Hudson
May 17, 2023
Health
First-of-its-kind drug for rare form of Lou Gehrig’s disease gets FDA approval
By
Matthew Perrone
and
The Associated Press
April 25, 2023
Health
There’s a small but very real chance that over-the-counter medication could send you to the emergency room, says team that studies medications
By
Macarius Mwinisungee Donneyong
,
Ximena Oyarzún-González
and
The Conversation
April 21, 2023
Most Popular
Success
Billionaire who sold two companies to Coca-Cola says he tries to convince people not to become entrepreneurs: 'Every...
By
Dave Smith
AI
Ray Dalio calls for wealth 'redistribution policy' when AI and humanoid robots start to benefit the 1% to 10% more than...
By
Nick Lichtenberg
Success
Blackstone exec says elite Ivy League degrees aren’t good enough—new analysts need to ‘work harder’ and be nice
By
Ashley Lutz